Considering that all tested cancer cell lines carried genetic perturbations negatively impacting p53 function (Supplementary Fig. 5a), we hypothesised that the fundamental differences in cellular responses to C-604 represented a direct consequence of defective p53 signalling. This evidence concerns the gene TP53 and cancer.